Related Experiment Videos
[Ankylosing spondylitis with type AA amyloidosis. 6 cases]
C Geffriaud1, L H Noël, P Blanche
1Département de Néphrologie, Hôpital Necker, Paris.
Presse Medicale (Paris, France : 1983)
|December 10, 1988
Summary
Systemic AA amyloidosis is a rare complication of ankylosing spondylitis, often leading to renal failure. Early recognition is crucial for managing this condition, which has a better prognosis than AL amyloidosis.
Area of Science:
- Nephrology
- Rheumatology
- Pathology
Context:
- Systemic AA amyloidosis is a serious complication.
- Ankylosing spondylitis is a chronic inflammatory disease.
- Renal failure is a common outcome in these patients.
Purpose:
- To study the characteristics and outcomes of AA amyloidosis in patients with ankylosing spondylitis.
- To investigate the prognosis of renal failure in this patient group.
- To highlight the diagnostic utility of specific staining methods.
Summary:
- The study examined 6 cases of systemic AA amyloidosis linked to ankylosing spondylitis.
- All patients developed renal failure approximately 19 years after ankylosing spondylitis onset.
- Rapid progression to end-stage renal failure occurred in three patients, independent of inflammation or colchicine treatment.
- A better prognosis was observed compared to AL amyloidosis, with all patients surviving 2-10 years post-diagnosis.
- Combined histochemical and immunological methods proved effective for amyloid deposit characterization.
Impact:
- Highlights amyloidosis as a rare but significant complication of ankylosing spondylitis.
- Emphasizes the importance of monitoring renal function in ankylosing spondylitis patients.
- Suggests a potential genetic predisposition for amyloidosis in this context.
- Underscores the need for considering amyloidosis in ankylosing spondylitis patients presenting with proteinuria or renal failure.